Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus in Ovarian and Endometrial Cancer
NCT01460979Phase 2Completed
- Sponsor
- AGO Study Group
- Start
- Oct 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in ovarian cancer, endometrial cancer (EC), sponsored by AGO Study Group. Started Oct 2011; status: completed.
02
Drugs
temsirolimus
03
Conditions
ovarian cancerendometrial cancer (EC)
Beyond the preview
Go deeper on NCT01460979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01460979.